Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Ondansetron Hydrochloride Injection

Approval Number

国药准字H20046059

Company成都利尔药业有限公司

Registration Date

January 6, 2021

Previous Approval Numbers

国药准字H20046059

Drug Information

Generic Name

盐酸昂丹司琼注射液

Dosage Form

注射剂(注射液)

Strength

4ml:8mg(按C18H19N3O计)

Drug Type

化学药品

Registration Date

January 6, 2021

Company Information

Applicant Company

Company Name成都利尔药业有限公司

Company Address

四川省成都市都江堰市四川都江堰经济开发区堰华路631号

Manufacturing Company

Company Name成都利尔药业有限公司

Company Address

都江堰市蒲阳镇堰华路631号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

盐酸昂丹司琼注射液 - NMPA 批准文号 | MedPath